Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

por Kawanami, Daiji, Takashi, Yuichi, Muta, Yoshimi, Oda, Naoki, Nagata, Dai, Takahashi, Hiroyuki, Tanabe, Makito
Publicado 2021

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case...

por Takashi, Yuichi, Toyokawa, Kyoko, Oda, Naoki, Muta, Yoshimi, Yokomizo, Hisashi, Fukumoto, Seiji, Kawanami, Daiji
Publicado 2022

SUN-026 Selective Androgen Receptor Modulator S42 Has Anabolic and Anti-Catabolic Effects on Cultured Myotubes

por Muta, Yoshimi, Tanaka, Tomoko, Hamaguchi, Yuriko, Hamanoue, Nobuya, Motonaga, Ryoko, Nomiyama, Takashi, Nawata, Hajime, Yanase, Toshihiko
Publicado 2019

Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes

por Muta, Yoshimi, Tanaka, Tomoko, Hamaguchi, Yuriko, Hamanoue, Nobuya, Motonaga, Ryoko, Tanabe, Makito, Nomiyama, Takashi, Nawata, Hajime, Yanase, Toshihiko
Publicado 2019